Purchase Order HHSN275201600863P

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $7,882.56 on March 29, 2016. The order is firm fixed price with no set-aside designation. Place of performance is San Diego, California. The order expired on April 24, 2016. No further details regarding the specific items or services procured are provided in the source material.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a $68,878.59 delivery order to Illumina, Inc. on September 27, 2018, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of December 31, 2018. No set-aside was used.</p>

The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $5,283.19 firm fixed price purchase order to Illumina, Inc. for genetic analysis products. The contract has a period of performance from January 6, 2017 through June 30, 2017 for products to be delivered to the agency location in Bethesda, Maryland. No additional details were provided regarding subcontractors or the specific genetic analysis...

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $12,061.94 on November 20, 2019 for instrument relocation services. Place of performance is San Diego, California. The order, issued as a firm fixed-price purchase order with no set-aside designation, de-obligates expired contract lines. The ultimate completion date is December 31, 2019.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a $37,343.66 delivery order to Illumina, Inc. on July 10, 2026.</p> <p>Place of performance is Bethesda, MD 20892. No set-aside was used for this order. The order is priced on a firm fixed-price basis with an ultimate completion date of July 10, 2026.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a $19,906.16 delivery order to Illumina, Inc. on June 20, 2014.</p> <p>Place of performance is Phoenix, Arizona. The order carries a firm fixed price and was completed by June 30, 2014. No set-aside was applied to this order.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $17,525.75 on March 2, 2016, for on-site field service engineer labor supporting reinstallation work. The order carries a firm fixed price and concludes January 31, 2021. Work is performed in San Diego, California.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a $41,064.40 delivery order to Illumina, Inc., on October 26, 2018, for genetic sequencing and genomic analysis equipment and reagents.</p> <p>Place of performance is San Diego, CA 92122. The order was awarded on a firm fixed-price basis with no set-aside. Ultimate completion date is September 2, 2020.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a delivery order to Illumina, Inc. on September 26, 2019, for reagents and consumables with a ceiling value of $500,027.24.</p> <p>Place of performance is San Diego, CA 92122. The order was firm fixed price with an ultimate completion date of November 2, 2020. No set-aside was used.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. for $78,707.44 on June 16, 2017, for Basic Service Level support with a firm fixed price structure. No set-aside was used. Work is performed in San Diego, California. The period of performance runs from June 23, 2017 through June 22, 2018.</p>